Eversheds Sutherland advises Pacira BioSciences, Inc., on its acquisition of GQ Bio Therapeutics

A man reading a Business newspaperA man reading a Business newspaper

Eversheds Sutherland advises Pacira BioSciences, Inc., on its acquisition of GQ Bio Therapeutics

March 03, 2025

GermanyUnited Kingdom
GermanyUnited Kingdom
GermanyUnited Kingdom
Eversheds Sutherland has advised NASDAQ listed Pacira BioSciences, Inc., on its acquisition of the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH.
Formats the Html codes.FormatFix the Html to be XHtml compliantFix Write Validate that the text is XHtml compliant.Validate Proofing

Eversheds Sutherland advised Pacira BioSciences on the German law aspects of the transaction.

Pacira acquired the outstanding stake in GQ Bio from the founders and venture capital investors like High-Tech Gründerfonds and IFB Innovationsstarter GmbH. This transaction builds upon Pacira’s previous investments in GQ Bio, as well as the two companies’ partnership for the development of a commercially scalable manufacturing process for PCRX-201 (enekinragene inzadenovec) and other products utilizing GQ Bio’s high-capacity adenovirus, or HCAd, gene therapy vector platform.

GQ Bio is a privately held biopharmaceutical company with a novel, high-capacity, local-delivery platform that makes genetic medicines more efficient and enables the use of large and multiple gene constructs. GQ Bio also brings to Pacira a preclinical portfolio of assets with disease-modifying potential in prevalent musculoskeletal diseases, and research and development talent.

The Eversheds Sutherland team was co-led by Partners Robin Johnson in the UK, Dr. Christian Mense and Dr. Christian Lindner in Germany.

The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.

Services

Key contacts

robinjohnson@eversheds-sutherland.com

Robin Johnson

Partner

United Kingdom

christianmense@eversheds-sutherland.com

Dr. Christian Mense

Partner

Munich, Germany

christianlindner@eversheds-sutherland.com

Dr. Christian Lindner

Counsel

Munich, Germany

Latest Insights

Latest News

Latest Events

  • hybrid
  • virtual | November 03, 2026
  • virtual | November 10, 2026
  • virtual | November 11, 2026
modern glass office building with tree background

legal updates

October 28, 2026

China: Climate Disclosure Implementation Framework Takes Shape

skyscrapers upward view symmetry glass facade modern corporate architecture

legal updates

October 27, 2026

Human judgement remains critical as tech transforms M&A: key takeaways from...

Classical stone columns historic building architecture detail

legal updates

October 26, 2026

Global payment matters - October 2026

EU-flags-at-the-European-Commission-Berlaymont-building-cropped

guides and reports

October 23, 2026

EU: Empowering Consumers for the Green Transition Directive

© Eversheds Sutherland 2026. All rights reserved. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.

Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed or affiliated firms and the members of Eversheds Sutherland (Europe) Limited and Eversheds Sutherland (Africa) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the Eversheds Sutherland Entities are in a partnership or are part of a global entity. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client. For further information about these Eversheds Sutherland Entities and Eversheds Sutherlands’ structure please see the Legal Notices page of this website. For information on Konexo please also see the Legal Notices page of this website.